Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 7, 2008; 14(9): 1339-1345
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1339
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1339
Figure 1 Validation of hepcidin expression in urine by MALDI-TOF MS.
A: (a) A human urine specimen showing the two dominant forms of hepcidin; hepcidin 20 (m/z 2195.3) and hepcidin 25 (m/z 2793.8). In addition the degradation product of hepcidin 25 hepcidin 22 could also be detected by MALDI-TOF MS (m/z 2440.5); (b) A human urine specimen completely devoid of hepcidin which when spiked with synthetic hepcidin 25 clearly shows a detectable peak at 2795.4 (c); B: Synthetic hepcidin was spiked into a low hepcidin containing urine sample at concentrations between 0-80 ng/mL and analysed by MALDI-TOF MS followed by analysis of the hepcidin 25 peak intensity.
- Citation: Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008; 14(9): 1339-1345
- URL: https://www.wjgnet.com/1007-9327/full/v14/i9/1339.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1339